Monopar Therapeutics Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Developments
Validive® Phase 2b/3 VOICE Trial Anticipates Go/No-Go Interim Readout by End of Next WeekCamsirubicin Phase…
Month: March 2023
Monopar Therapeutics Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Developments
Validive® Phase 2b/3 VOICE Trial Anticipates Go/No-Go Interim Readout by End of Next WeekCamsirubicin Phase…
Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines
Collaboration will extend the applications of each company’s platform through discovery and development of novel…
Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines
Collaboration will extend the applications of each company’s platform through discovery and development of novel…
Castellum, Inc. Announces Closing of GTMR Acquisition
Castellum, Inc. Announces Closing of GTMR Acquisition Castellum, Inc. (NYSE-American: CTM), a cybersecurity and electronic…
Castellum, Inc. Announces Closing of GTMR Acquisition
Castellum, Inc. Announces Closing of GTMR Acquisition Castellum, Inc. (NYSE-American: CTM), a cybersecurity and electronic…
Orange Grove Bio Expands Academic Collaboration Activities Internationally Through New Strategic Partnerships
Collaborations with Yonsei University Health System and Pohang University of Science and Technology Designed to…
Orange Grove Bio Expands Academic Collaboration Activities Internationally Through New Strategic Partnerships
Collaborations with Yonsei University Health System and Pohang University of Science and Technology Designed to…
Applied Therapeutics Reports Fourth Quarter and Year-end 2022 Financial Results
Progress in Three Phase 3 Trials in Areas of High Unmet Clinical Need, Including Positive…
Applied Therapeutics Reports Fourth Quarter and Year-end 2022 Financial Results
Progress in Three Phase 3 Trials in Areas of High Unmet Clinical Need, Including Positive…
TCR² Therapeutics Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update
TCR² and Adaptimmune announce strategic combination to create a preeminent cell therapy company focused on…
TCR² Therapeutics Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update
TCR² and Adaptimmune announce strategic combination to create a preeminent cell therapy company focused on…
Affimed Reports 2022 Financial Results and Operational Progress
AFM13 combination with AB-101 NK cells: On track for IND filing in H1 2023 and…
Affimed Reports 2022 Financial Results and Operational Progress
AFM13 combination with AB-101 NK cells: On track for IND filing in H1 2023 and…
Verizon Free Trial gives you 30 days of 5G Ultra Wideband, on us. No strings attached.
BASKING RIDGE, N.J., March 23, 2023 (GLOBE NEWSWIRE) — What’s the news: Attention non-Verizon customers…
Verizon Free Trial gives you 30 days of 5G Ultra Wideband, on us. No strings attached.
BASKING RIDGE, N.J., March 23, 2023 (GLOBE NEWSWIRE) — What’s the news: Attention non-Verizon customers…
Verizon to expand high-speed broadband to rural households in Bedford County
NEW YORK, March 23, 2023 (GLOBE NEWSWIRE) — To bring high speed internet to rural…
Verizon to expand high-speed broadband to rural households in Bedford County
NEW YORK, March 23, 2023 (GLOBE NEWSWIRE) — To bring high speed internet to rural…
Progress Offers Free Application Development Training for Anyone Who Wants to Learn Code
Online program intended for new and experienced developers who are interested in building modern applications…
Progress Offers Free Application Development Training for Anyone Who Wants to Learn Code
Online program intended for new and experienced developers who are interested in building modern applications…